Frank A. Jaeger
Keine laufenden Positionen mehr
Profil
Frank A.
Jaeger worked as a Director-Regional Sales at AbbVie, Inc. from 2014 to 2019.
He then worked as a Chief Commercial Officer at Clarus Therapeutics, Inc. from 2019 to 2022.
He also worked as a Senior VP-Marketing & Business Development at Blue Water Biotech, Inc. Additionally, he worked as a Chief Commercial Officer at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Mr. Jaeger received his undergraduate and graduate degrees from the University of Illinois.
He also received an MBA from Lake Forest Graduate School of Management.
Ehemalige bekannte Positionen von Frank A. Jaeger
| Unternehmen | Position | Ende |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 14.11.2022 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Corporate Officer/Principal | 14.11.2022 |
| ABBVIE INC. | Sales & Marketing | 01.08.2019 |
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Sales & Marketing | - |
Ausbildung von Frank A. Jaeger
| University of Illinois | Graduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
